These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25243412)

  • 21. P-selectin mediates the adhesion of sickle erythrocytes to the endothelium.
    Matsui NM; Borsig L; Rosen SD; Yaghmai M; Varki A; Embury SH
    Blood; 2001 Sep; 98(6):1955-62. PubMed ID: 11535535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selectins--potential pharmacological targets?
    Kneuer C; Ehrhardt C; Radomski MW; Bakowsky U
    Drug Discov Today; 2006 Nov; 11(21-22):1034-40. PubMed ID: 17055414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukocyte adhesion and the pathophysiology of sickle cell disease.
    Okpala I
    Curr Opin Hematol; 2006 Jan; 13(1):40-4. PubMed ID: 16319686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells.
    Okpala I; Daniel Y; Haynes R; Odoemene D; Goldman J
    Eur J Haematol; 2002 Sep; 69(3):135-44. PubMed ID: 12406006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innovations in Targeted Anti-Adhesion Treatment for Sickle Cell Disease.
    Kanter J; Lanzkron S
    Clin Pharmacol Ther; 2020 Jan; 107(1):140-146. PubMed ID: 31617585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A microfluidic device for assessment of E-selectin-mediated neutrophil recruitment to inflamed endothelium and prediction of therapeutic response in sickle cell disease.
    Man Y; Kucukal E; Liu S; An R; Goreke U; Wulftange WJ; Sekyonda Z; Bode A; Little JA; Manwani D; Stavrou EX; Gurkan UA
    Biosens Bioelectron; 2023 Feb; 222():114921. PubMed ID: 36521205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.
    Telen MJ; Wun T; McCavit TL; De Castro LM; Krishnamurti L; Lanzkron S; Hsu LL; Smith WR; Rhee S; Magnani JL; Thackray H
    Blood; 2015 Apr; 125(17):2656-64. PubMed ID: 25733584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intravenous Rivipansel.
    Tammara BK; Ryan K; Plotka A; Shafer FE; Wei H; Readett D; Fang A; Korth-Bradley JM
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):918-928. PubMed ID: 32579796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analogues of the pan-selectin antagonist rivipansel (GMI-1070).
    Wagner B; Smieško M; Jakob RP; Mühlethaler T; Cramer J; Maier T; Rabbani S; Schwardt O; Ernst B
    Eur J Med Chem; 2024 Jun; 272():116455. PubMed ID: 38728868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary alpha-linolenic acid reduces platelet activation and collagen-mediated cell adhesion in sickle cell disease mice.
    Stivala S; Gobbato S; Bonetti N; Camici GG; Lüscher TF; Beer JH
    J Thromb Haemost; 2022 Feb; 20(2):375-386. PubMed ID: 34758193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tandem P-selectin glycoprotein ligand immunoglobulin prevents lung vaso-occlusion in sickle cell disease mice.
    Vats R; Tutuncuoglu E; Pradhan-Sundd T; Tejero J; Shaw GD; Sundd P
    Exp Hematol; 2020 Apr; 84():1-6.e1. PubMed ID: 32243995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel.
    Ohno K; Tanaka H; Samata N; Jakubowski JA; Tomizawa A; Mizuno M; Sugidachi A
    Thromb Res; 2014 Oct; 134(4):889-94. PubMed ID: 25130912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocyte membrane sulfatide plays a crucial role in the adhesion of sickle erythrocytes to endothelium.
    Zhou Z; Thiagarajan P; Udden M; Lòpez JA; Guchhait P
    Thromb Haemost; 2011 Jun; 105(6):1046-52. PubMed ID: 21437360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease.
    Telen MJ
    Hematology Am Soc Hematol Educ Program; 2007; ():84-90. PubMed ID: 18024614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder.
    Okpala I
    Blood Rev; 2004 Mar; 18(1):65-73. PubMed ID: 14684149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selectins promote tumor metastasis.
    Läubli H; Borsig L
    Semin Cancer Biol; 2010 Jun; 20(3):169-77. PubMed ID: 20452433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusion.
    Liu Y; Su S; Shayo S; Bao W; Pal M; Dou K; Shi PA; Aygun B; Campbell-Lee S; Lobo CA; Mendelson A; An X; Manwani D; Zhong H; Yazdanbakhsh K
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37490346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting selectins for the treatment of respiratory diseases.
    Romano SJ; Slee DH
    Curr Opin Investig Drugs; 2001 Jul; 2(7):907-13. PubMed ID: 11757789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain.
    Machelska H; Brack A; Mousa SA; Schopohl JK; Rittner HL; Schäfer M; Stein C
    Br J Pharmacol; 2004 Jun; 142(4):772-80. PubMed ID: 15159283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.